Literature DB >> 31230676

Tapering of SSRI treatment to mitigate withdrawal symptoms.

Sudhakar Selvaraj1, Sameer Jauhar2, David S Baldwin3, Philip J Cowen4, Guy Goodwin4, Joseph F Hayes5, David J Nutt6, Mattia Veronese7, Allan H Young2.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31230676      PMCID: PMC7613095          DOI: 10.1016/S2215-0366(19)30183-X

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   77.056


× No keyword cloud information.
  4 in total

Review 1.  Tapering of SSRI treatment to mitigate withdrawal symptoms.

Authors:  Mark Abie Horowitz; David Taylor
Journal:  Lancet Psychiatry       Date:  2019-03-05       Impact factor: 27.083

2.  Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database.

Authors:  Arif Khan; Robyn M Leventhal; Shirin R Khan; Walter A Brown
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

3.  'Doing the right thing': factors influencing GP prescribing of antidepressants and prescribed doses.

Authors:  Chris F Johnson; Brian Williams; Stephen A MacGillivray; Nadine J Dougall; Margaret Maxwell
Journal:  BMC Fam Pract       Date:  2017-06-17       Impact factor: 2.497

4.  Influences on antidepressant prescribing trends in the UK: 1995-2011.

Authors:  Becky Mars; Jon Heron; David Kessler; Neil M Davies; Richard M Martin; Kyla H Thomas; David Gunnell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-11-24       Impact factor: 4.328

  4 in total
  1 in total

Review 1.  Medicines associated with dependence or withdrawal: a mixed-methods public health review and national database study in England.

Authors:  John Marsden; Martin White; Fizz Annand; Peter Burkinshaw; Serena Carville; Brian Eastwood; Michael Kelleher; Jonathan Knight; Rosanna O'Connor; Anh Tran; Peter Willey; Felix Greaves; Stephen Taylor
Journal:  Lancet Psychiatry       Date:  2019-10-03       Impact factor: 27.083

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.